Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slusher

Showing results (661-670 of 672) with videos related to

Pageof 68
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2016
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancerAmira Elgogary, Qingguo Xu, Brad Poore, et al.
Science Advances|November 16, 2022
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrugRana Rais, Kathryn M Lemberg, Lukáš Tenora, et al.
Cancer Research|December 2, 2017
Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term RecoveryKrystyna M Wozniak, James J Vornov, Ying Wu, et al.
The Journal of Clinical Investigation|April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cellsMin-Hee Oh, Im-Hong Sun, Liang Zhao, et al.
Journal of Neurovirology|February 26, 2014
Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIVJennifer M Coughlin, Yuchuan Wang, Shuangchao Ma, et al.
ACS Pharmacology & Translational Science|February 19, 2026
Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand PharmacokineticsMohammad Alkhatib, Franziska M Jakobs, John N Hanson, et al.
The Journal of Clinical Investigation|April 28, 2015
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesisYan Xiang, Zachary E Stine, Jinsong Xia, et al.
Cancer Immunology Research|May 3, 2024
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder CancersMonali Praharaj, Fan Shen, Alex J Lee, et al.
PNAS Nexus|January 30, 2023
Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areataJerry Tsai, Sadakatali Gori, Jesse Alt, et al.
Science Advances|December 16, 2022
In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinomaAkash K Kaushik, Amy Tarangelo, Lindsey K Boroughs, et al.
Pageof 68

Showing results (661-670 of 672) with videos related to

Sort By:
Pageof 68
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2016
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancerAmira Elgogary, Qingguo Xu, Brad Poore, et al.
Science Advances|November 16, 2022
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrugRana Rais, Kathryn M Lemberg, Lukáš Tenora, et al.
Cancer Research|December 2, 2017
Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term RecoveryKrystyna M Wozniak, James J Vornov, Ying Wu, et al.
The Journal of Clinical Investigation|April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cellsMin-Hee Oh, Im-Hong Sun, Liang Zhao, et al.
Journal of Neurovirology|February 26, 2014
Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIVJennifer M Coughlin, Yuchuan Wang, Shuangchao Ma, et al.
ACS Pharmacology & Translational Science|February 19, 2026
Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand PharmacokineticsMohammad Alkhatib, Franziska M Jakobs, John N Hanson, et al.
The Journal of Clinical Investigation|April 28, 2015
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesisYan Xiang, Zachary E Stine, Jinsong Xia, et al.
Cancer Immunology Research|May 3, 2024
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder CancersMonali Praharaj, Fan Shen, Alex J Lee, et al.
PNAS Nexus|January 30, 2023
Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areataJerry Tsai, Sadakatali Gori, Jesse Alt, et al.
Science Advances|December 16, 2022
In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinomaAkash K Kaushik, Amy Tarangelo, Lindsey K Boroughs, et al.
Pageof 68